Sign Up Today and Learn More About Rege Nephro Stock
Invest in or calculate the value of your shares in Rege Nephro or other pre-IPO companies through EquityZen's platform.
Rege Nephro Stock (REGN)
Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.
About Rege Nephro Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
Rege Nephro Press Mentions
Stay in the know about the latest news on Rege Nephro
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
en • Apr 15, 2025
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
prnewswire • Apr 15, 2025
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
biospace • Apr 15, 2025
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
morningstar • Apr 15, 2025
Rege Nephro Co. Closes Series B Funding
finsmes • Oct 07, 2024
Rege Nephro Management
Leadership team at Rege Nephro
Founder & Chief Scientific Advisor
Kenji Osafune
Board Member & Chief Scientific Advisor
Kenji Osafune
Join now and verify your accreditation status to gain access to:
- Rege Nephro Current Valuation
- Rege Nephro Stock Price
- Rege Nephro Management
- Available deals in Rege Nephro and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Rege Nephro Cap Table and Funding History by Share Class and Liquidity Preferences
- Rege Nephro Revenue and Financials
- Rege Nephro Highlights
- Rege Nephro Business Model
- Rege Nephro Risk Factors
- Rege Nephro Research Report from SACRA Research
Trading Rege Nephro Stock
How to invest in Rege Nephro stock?
Accredited investors can buy pre-IPO stock in companies like Rege Nephro through EquityZen funds. These investments are made available by existing Rege Nephro shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Rege Nephro stock?
Shareholders can sell their Rege Nephro stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
